Steven Mintz - Apr 1, 2024 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ STEVEN MINTZ
Stock symbol
SER
Transactions as of
Apr 1, 2024
Transactions value $
$0
Form type
4
Date filed
4/3/2024, 08:59 PM
Previous filing
Jan 18, 2024
Next filing
May 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Award $0 +40K +2207.51% $0.00 41.8K Apr 1, 2024 Common Stock 40K $11.83 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest in three equal installments on April 1, 2025, April 1, 2026 and April 1, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
F2 Number of derivative securities determined after giving effect to a reverse split of the Issuer's common stock of 1-for-35.17.